Antibodies specific for GUCY2c and uses thereof
US12269896B2 · kind B2 · utility
0Cited by
51References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2022 |
| Grant date | Apr 8, 2025 |
| Priority date | — |
| Expiry date | Dec 3, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel antibodies that specifically bind to GUCY2c and uses thereof in the treatment of cancer. The present invention further provides novel bispecific antibodies comprising such antibodies and uses thereof in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.